AUROPHARMA

📌 Aurobindo Pharma – Simple Share Analysis (SEBI-Compliant) Company: Aurobindo Pharma Ltd (Pharmaceuticals) Business: Large global generics and formulations company with presence in multiple markets and product lines including biosimilars and specialty drugs. 🧾 Fundamentals (Recent) Aurobindo Pharma showed revenue growth and improved profitability in recent annual results. Earnings per share (EPS) improved significantly year-on-year, indicating better earnings performance. The company continues expanding product portfolio and geographic reach. Note: Fundamentals reflect company performance, not price movement. 📊 Technical Price Levels (Latest) (For reference to recent price action — not a recommendation) Support Levels: • Around ₹1,093–₹1,117 (near key recorded support zones) Resistance Levels: • Around ₹1,140–₹1,164 range where price faces supply pressure. Trend Observation: • Moving averages and momentum indicators currently suggest a mixed/neutral near-term trend.